K Drug
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for K Drug, covering 2021-08-20 to 2021-08-20. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC) [Phase 3]